Your session is about to expire
← Back to Search
Ocufolin for Eye Conditions
Study Summary
This trial will help researchers understand if these devices can be used to study different eye conditions and if Ocufolin can help improve vision.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have an ongoing eye condition.I can keep my eye open for pictures.Your hemoglobin A1c level is 10 or lower.My blood pressure is normal, with or without medication.Your blood homocysteine level is higher than 9.You do not have damage to the blood vessels in your retina or swelling in the center of your retina.You are not able to read and sign the informed consent form.I have been diagnosed with Alzheimer's, mild cognitive impairment, MS, dry eye, myopia, diabetes, or have had a stroke.I have had eye surgery or an injury within the last 6 months.I consider myself to be in good health.I am over 18 and can legally consent.I have been diagnosed with Alzheimer's, mild cognitive impairment, MS, dry eye, myopia, diabetes, or have had a stroke.Your eyesight is 20/80 or better.You are not able to handle bright light during imaging.I can keep my eye open for pictures.I consider myself to be in good health.My corneas and lens are clear.I have a specific genetic mutation and mild to moderate eye blood vessel issues.I have not had eye surgery or an injury in the last 6 months.This study is only for observing and gathering information about the participants.
- Group 1: Interventional Phase - Ocufolin Group
- Group 2: Observational Phase Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research study open to adults aged 18 and over?
"The criteria for entry into this study necessitates that participants are between the ages of 18 and 99. Aside from this trial, there are additional 122 studies catered to those under 18 years old and 813 more suitable for individuals above 65."
Is recruitment for participants ongoing?
"The trial is still open for recruitment, as indicated by information on clinicaltrials.gov; the posting was placed on January 1st 2007 and revised October 18th 2022."
What is the total amount of participants included in this research endeavor?
"Affirmative, the trial is currently open to participants. It was initially posted on January 1st 2007 and its latest update occurred on October 18th 2022. A total of 5000 individuals are needed across a single site for this research endeavour."
What criteria must a participant fulfill to qualify for this clinical trial?
"This clinical trial seeks to enroll around 5000 participants with diabetic retinopathy aged between 18 and 99. Eligibility requirements must be met in order to join the study."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger